These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 6326566)

  • 1. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair.
    Di Minno G; Capitanio AM; Thiagarajan P; Martinez J; Murphy S
    Blood; 1983 Jun; 61(6):1054-9. PubMed ID: 6301579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of human platelet fibrinogen receptors by epinephrine in the absence of released ADP.
    Peerschke EI
    Blood; 1982 Jul; 60(1):71-7. PubMed ID: 6282365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
    Plow EF; Marguerie GA
    J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists.
    Shattil SJ; Budzynski A; Scrutton MC
    Blood; 1989 Jan; 73(1):150-8. PubMed ID: 2535942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS; Vilaire G; Burch JW
    J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of epinephrine on the aggregation response of aspirin-treated platelets.
    Rao GH; Johnson GJ; White JG
    Prostaglandins Med; 1980 Jul; 5(1):45-58. PubMed ID: 7403340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
    Parker RI; Gralnick HR
    Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets.
    Chronos NA; Wilson DJ; Janes SL; Hutton RA; Buller NP; Goodall AH
    Clin Sci (Lond); 1994 Nov; 87(5):575-80. PubMed ID: 7533066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of fibrinogen-binding sites on stored platelets on stimulation by aggregating agents--an electron microscopic study.
    Kitajima H; Takayama S; Yasunaga K
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):93-101. PubMed ID: 2741653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin.
    Sweatt JD; Johnson SL; Cragoe EJ; Limbird LE
    J Biol Chem; 1985 Oct; 260(24):12910-9. PubMed ID: 2997148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.